Vital KSK Holdings, Inc.

3151

JP3778280002

Pharmaceuticals

Delayed Japan Exchange Other stock markets 11:30:00 03/07/2024 am IST			5-day change	1st Jan Change
1,307 ^JPY	-1.88%		-9.17%	+25.19%

01/07	Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 13, 2024.	CI
15/05	Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	MT

Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 13, 2024.

July 01, 2024 at 07:30 am IST

From May 13, 2024 to June 30, 2024, the company has repurchased 511,600 shares, representing 1.02% for ¥653.36 million. With this, the company has completed the repurchase of 511,600 shares, representing 1.02% for ¥653.36 million under the buyback announced on May 13, 2024.

Latest news about Vital KSK Holdings, Inc.

Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 13, 2024.	01/07	CI
Caution Ahead of US Inflation Data Leaves Japanese Shares Subdued	15/05	MT
Vital KSK to Dispose of Treasury Shares Worth 108 Million Yen as Restricted Stock Compensation	15/05	MT
Vital KSK Board OKs Up to 3 Billion Yen Share Buyback	15/05	MT
Vital KSK Holdings, Inc. Announces Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 5, 2024; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2025	14/05	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2025	13/05	CI
Vital KSK Holdings, Inc. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2025	13/05	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 2,000,000 shares, representing 3.85% for ¥3,000 million.	13/05	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	13/05	CI
Vital KSK Holdings, Inc. Revises Consolidated Earnings Guidance for the Year Ended March 31, 2024	07/02	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on November 6, 2023.	08/11	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on November 6, 2023, has closed with 600,000 shares, representing 1.18% for ¥669.6 million.	08/11	CI
Vital KSK Holdings, Inc. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on December 5, 2023	06/11	CI
Vital KSK Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024	06/11	CI
Vital KSK Holdings, Inc. announces an Equity Buyback for 700,000 shares, representing 1.38% for ¥840 million.	06/11	CI
Vital KSK Holdings, Inc. authorizes a Buyback Plan.	06/11	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	25/23/25	CI
Vital KSK Holdings, Inc.'s Equity Buyback announced on May 12, 2023, has closed with 1,000,000 shares, representing 1.94% for ¥956.92 million.	22/23/22	CI
VITAL KSK HOLDINGS, INC. Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2024	04/23/04	CI
VITAL KSK HOLDINGS, INC. Provides Dividend Guidance for the Second Quarter of Fiscal Year Ending March 31, 2024	04/23/04	CI
VITAL KSK HOLDINGS, INC. Provides Year End Dividend Guidance for the Fiscal Year Ending March 31, 2024	04/23/04	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	02/23/02	CI
Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 12, 2023.	03/23/03	CI
Vital KSK Announces Voting Results	30/23/30	CI
Vital KSK Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	12/23/12	CI

Chart Vital KSK Holdings, Inc.

Duration

Period

More charts

Company Profile

VITAL KSK HOLDINGS, INC. is a Japan-based holding company, principally engaged in the wholesale of drugs. The Pharmaceutical Wholesale segment is engaged in the wholesale of pharmaceuticals, diagnostics, medical equipment, materials to hospitals, medical practitioners, pharmacies and other medical institutions. The others business is engaged in dispensing pharmacy business, retail of pharmaceutical products, wholesale of agricultural chemicals and veterinary drugs, transportation business, nursing care business, consulting services for medical institutions, property insurance agency business, real estate brokerage business, as well as parking business.

Sector

Pharmaceuticals

Calendar

30/07/2024 - Q1 2024 Earnings Release (Projected)

More about the company

	1st Jan change	Capi.
VITAL KSK HOLDINGS, INC.	+25.19%	410M
MCKESSON CORPORATION	+26.32%	75.86B
CARDINAL HEALTH, INC.	-4.23%	23.51B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+15.24%	8.76B
SINOPHARM GROUP CO. LTD.	+1.47%	8.31B
HUADONG MEDICINE CO., LTD	-33.21%	6.66B
H. LUNDBECK A/S	+19.05%	5.45B
GALENICA AG	+1.31%	4.05B
EBOS GROUP LIMITED	-8.73%	3.8B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	-9.28%	3.33B

Pharmaceuticals Wholesale

Vital KSK Holdings, Inc.

Equities

3151

JP3778280002

Pharmaceuticals

Tranche Update on Vital KSK Holdings, Inc.'s Equity Buyback Plan announced on May 13, 2024.

Latest news about Vital KSK Holdings, Inc.

Chart Vital KSK Holdings, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Pharmaceuticals Wholesale